Patents by Inventor Matthew Netherton

Matthew Netherton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240101534
    Abstract: The present disclosure features compounds and methods useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: November 22, 2021
    Publication date: March 28, 2024
    Inventors: Matthew NETHERTON, Francois BRUCELLE, Jing DENG, Johannes H. VOIGT
  • Publication number: 20240067642
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: June 29, 2023
    Publication date: February 29, 2024
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
  • Publication number: 20240024488
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: November 22, 2021
    Publication date: January 25, 2024
    Inventors: Matthew NETHERTON, Francois BRUCELLE, Jing DENG, Johannes H. VOIGT
  • Publication number: 20240002382
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: June 29, 2023
    Publication date: January 4, 2024
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
  • Publication number: 20230416246
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: June 29, 2023
    Publication date: December 28, 2023
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
  • Publication number: 20230348452
    Abstract: The present disclosure features compounds and methods useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2021
    Publication date: November 2, 2023
    Inventors: Matthew NETHERTON, Shawn E.R. SCHILLER, Jing DENG, Neville John ANTHONY, Francois BRUCELLE, Sabine K. RUPPEL, Johannes H. VOIGT
  • Publication number: 20230331722
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: June 29, 2023
    Publication date: October 19, 2023
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
  • Patent number: 11787800
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: October 17, 2023
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt, Matthew Netherton, Francois Brucelle
  • Publication number: 20230150974
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: April 6, 2021
    Publication date: May 18, 2023
    Inventors: Matthew NETHERTON, Francois BRUCELLE
  • Publication number: 20230077730
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 16, 2023
    Applicants: Foghorn Therapeutics Inc., Foghorn Therapeutics Inc.
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON, Francois BRUCELLE
  • Publication number: 20230066136
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 2, 2023
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
  • Publication number: 20230065463
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 2, 2023
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON, Francois BRUCELLE
  • Patent number: 11560381
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: January 24, 2023
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt, Matthew Netherton
  • Patent number: 11414416
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: August 16, 2022
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt, Matthew Netherton
  • Publication number: 20220098190
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 31, 2022
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON, Francois BRUCELLE, Rishi G. VASWANI
  • Publication number: 20220048906
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Application
    Filed: July 22, 2021
    Publication date: February 17, 2022
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON, Francois BRUCELLE
  • Publication number: 20080103138
    Abstract: The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R4 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, methods of preparing these compounds and their use as pharmaceutical compositions.
    Type: Application
    Filed: December 19, 2007
    Publication date: May 1, 2008
    Inventors: Thomas Trieselmann, Rainer Walter, Matthew Netherton, Marco Santagostino, Bradford Hamilton
  • Publication number: 20070142371
    Abstract: Disclosed compounds of formula (I) which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: January 30, 2007
    Publication date: June 21, 2007
    Inventors: Derek Cogan, Ming-Hong Hao, Victor Kamhi, Matthew Netherton, Alan Swinamer, Craig Miller
  • Publication number: 20070112033
    Abstract: The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R4 have the meanings given in ths claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, methods of preparing these compounds and their use as pharmaceutical compositions.
    Type: Application
    Filed: October 19, 2006
    Publication date: May 17, 2007
    Inventors: Thomas Trieselmann, Rainer Walter, Matthew Netherton, Marco Santagostino, Bradford Hamilton
  • Publication number: 20070105906
    Abstract: The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 and R2 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, methods of preparing these compounds and their use as pharmaceutical compositions.
    Type: Application
    Filed: October 19, 2006
    Publication date: May 10, 2007
    Inventors: Rainer Walter, Bradford Hamilton, Thomas Trieselmann, Matthew Netherton, Marco Santagostino, Ingo Konetzki